Cargando…
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors
Adoptive T-cell therapy aims to achieve lasting tumor clearance, requiring enhanced engraftment and survival of the immune cells. Cytokines are paramount modulators of T-cell survival and proliferation. Cytokine receptors signal via ligand-induced dimerization, and this principle has been hijacked u...
Autores principales: | Righi, Matteo, Gannon, Isaac, Robson, Matthew, Srivastava, Saket, Kokalaki, Evangelia, Grothier, Thomas, Nannini, Francesco, Allen, Christopher, Bai, Yuchen V., Sillibourne, James, Cordoba, Shaun, Thomas, Simon, Pule, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472109/ https://www.ncbi.nlm.nih.gov/pubmed/37352396 http://dx.doi.org/10.1158/2326-6066.CIR-22-0640 |
Ejemplares similares
-
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023) -
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction
por: Hotblack, Alastair, et al.
Publicado: (2021) -
Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy
por: McKenzie, Callum, et al.
Publicado: (2023) -
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Ferreira, Leonardo M. R., et al.
Publicado: (2021) -
Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)